{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:32:17Z","timestamp":1759332737999},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":2540,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Health, Labor, and Welfare of Japan"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1093\/annonc\/mds147","type":"journal-article","created":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T04:09:18Z","timestamp":1339733358000},"page":"3129-3137","source":"Crossref","is-referenced-by-count":17,"title":["Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas"],"prefix":"10.1016","volume":"23","author":[{"given":"T.","family":"Mimae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.M.","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Asamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mds147_bb0010","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.athoracsur.2009.11.057","article-title":"Masaoka stage and histologic grade predict prognosis in patients with thymic carcinoma","volume":"89","author":"Hosaka","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1093\/annonc\/mds147_bb0015","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/cncr.10226","article-title":"The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients","volume":"94","author":"Okumura","year":"2002","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds147_bb0020","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1038\/sj.onc.1203957","article-title":"The protein tyrosine kinase family of the human genome","volume":"19","author":"Robinson","year":"2000","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/mds147_bb0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1677\/erc.0.0080161","article-title":"Receptor tyrosine kinase signalling as a target for cancer intervention strategies","volume":"8","author":"Zwick","year":"2001","journal-title":"Endocr Relat Cancer"},{"key":"10.1093\/annonc\/mds147_bb0030","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.1073\/pnas.0405220101","article-title":"EGF receptor gene mutations are common in lung cancers from \u201cnever smokers\u201d and are associated with sensitivity of tumors to gefitinib and erlotinib","volume":"101","author":"Pao","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mds147_bb0035","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mds147_bb0040","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1158\/0008-5472.CAN-10-0898","article-title":"MET kinase inhibitor SGX523 synergizes with epidermal growth factor receptor inhibitor erlotinib in a hepatocyte growth factor-dependent fashion to suppress carcinoma growth","volume":"70","author":"Zhang","year":"2010","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mds147_bb0045","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/1471-2407-10-556","article-title":"Efficacy of c-Met inhibitor for advanced prostate cancer","volume":"10","author":"Tu","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1093\/annonc\/mds147_bb0050","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3171\/jns.1998.88.5.0884","article-title":"Antagonist effect of insulin-like growth factor I on protein kinase inhibitor-mediated apoptosis in human glioblastoma cells in association with bcl-2 and bcl-xL","volume":"88","author":"Toms","year":"1998","journal-title":"J Neurosurg"},{"key":"10.1093\/annonc\/mds147_bb0055","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1158\/1535-7163.MCT-09-1173","article-title":"ARQ 197, a novel and selective inhibitor of the human c-Met receptor tyrosine kinase with antitumor activity","volume":"9","author":"Munshi","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1093\/annonc\/mds147_bb0060","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/cncr.20811","article-title":"Protein expression and gene amplification of epidermal growth factor receptor in thymomas","volume":"103","author":"Ionescu","year":"2005","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds147_bb0065","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/JTO.0b013e3181d86a30","volume":"5","author":"Aisner","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mds147_bb0070","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/JTO.0b013e3181e392a8","article-title":"Insulin-like growth factor-1 receptor expression in thymic malignancies","volume":"5","author":"Girard","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mds147_bb0075","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1002\/cncr.25367","article-title":"Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas","volume":"116","author":"Zucali","year":"2010","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds147_bb0080","series-title":"World Health Organization Classification of Tumours","article-title":"Pathology and genetics of tumors of the lung, pleura, thymus and heart","author":"Travis","year":"2004"},{"key":"10.1093\/annonc\/mds147_bb0085","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/JTO.0b013e318241655f","article-title":"c-MET\/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas","volume":"7","author":"Tsuta","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mds147_bb0090","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"Wolff","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds147_bb0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1746-1596-1-19","article-title":"Stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors: the EGFR fluorescence in situ hybridization assay","volume":"1","author":"Varella-Garcia","year":"2006","journal-title":"Diagn Pathol"},{"key":"10.1093\/annonc\/mds147_bb0100","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1002\/cncr.26061","article-title":"Steroid receptor expression in thymomas and thymic carcinomas","volume":"117","author":"Mimae","year":"2011","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds147_bb0105","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1200\/JCO.2009.24.6611","article-title":"Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression","volume":"28","author":"Dziadziuszko","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds147_bb0110","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/carcin\/bgl247","article-title":"Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma","volume":"28","author":"Imsumran","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1093\/annonc\/mds147_bb0115","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1158\/1078-0432.CCR-10-2040","article-title":"Comparative prognostic value of epidermal growth factor quantitative protein expression compared with FISH for head and neck squamous cell carcinoma","volume":"17","author":"Pectasides","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mds147_bb0120","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.oraloncology.2011.03.020","article-title":"Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas","volume":"47","author":"Szabo","year":"2011","journal-title":"Oral Oncol"},{"key":"10.1093\/annonc\/mds147_bb0125","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1200\/JCO.2011.36.0487","article-title":"Thymic malignancies: from clinical management to targeted therapies","volume":"29","author":"Kelly","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds147_bb0130","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/JTO.0b013e3181ae2828","article-title":"Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2\/ErbB2 and HER3\/ErbB3 in non-small cell lung cancer","volume":"4","author":"Kashihara","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mds147_bb0135","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1309\/AJCP12MHRTFZJPKW","article-title":"Visualization of FISH Probes by dual-color chromogenic in situ hybridization","volume":"133","author":"Hoff","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1093\/annonc\/mds147_bb0140","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1440-1827.2010.02553.x","article-title":"Evaluation of HER2 gene amplification in invasive breast cancer using a dual-color chromogenic in situ hybridization (dual CISH)","volume":"60","author":"Kato","year":"2010","journal-title":"Pathol Int"},{"key":"10.1093\/annonc\/mds147_bb0145","doi-asserted-by":"crossref","first-page":"e7273","DOI":"10.1371\/journal.pone.0007273","article-title":"High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507)","volume":"4","author":"Gong","year":"2009","journal-title":"PLoS One"},{"key":"10.1093\/annonc\/mds147_bb0150","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1158\/1078-0432.CCR-10-1689","article-title":"Heat shock protein 90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumors","volume":"17","author":"Breinig","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mds147_bb0155","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1200\/JCO.2005.04.3547","article-title":"Phase I\/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck","volume":"24","author":"Bourhis","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds147_bb0160","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mds147_bb0165","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1158\/0008-5472.CAN-06-0191","article-title":"KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer","volume":"66","author":"Lievre","year":"2006","journal-title":"Cancer Res"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419374770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419374770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/23\/12\/3129\/13786348\/mds147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T19:53:12Z","timestamp":1625169192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419374770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0923753419374770"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mds147","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}